Download
s13104-021-05836-w.pdf 798,56KB
WeightNameValue
1000 Titel
  • Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
1000 Autor/in
  1. Schick, Martin |
  2. Pippir, Jonas |
  3. Struck, Manuel F. |
  4. Brugger, Jürgen |
  5. Neuhaus, Winfried |
  6. Wunder, Christian |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-27
1000 Erschienen in
1000 Quellenangabe
  • 14(1):434
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13104-021-05836-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627096/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Objective!#!Colloid solutions are commonly used to maintain perioperative fluid homeostasis. In regard to perioperative infant-centered care, data about the impact of colloids are rare. New data suggest a possible positive effect of hydroxyethyl starch (HES) concerning blood brain barrier. Therefore we conduct a retrospective single center study of children scheduled for neurosurgery, age < five with a blood loss > 10% of body blood volume, receiving either 6% HES 130/0.4 or 5% human albumin (HA).!##!Results!#!Out of 913 patients, 86 were included (HES = 30; HA = 56). Compared to HES [16.4 ± 9.2 ml/kg body weight (mean ± SD)] HA group received more colloid volume (25.7 ± 11.3), which had more blood loss [HA 54.8 ± 45.0; HES 30.5 ± 30.0 (%) estimated blood volume] and higher fluid balances. Fibrinogen was decreased and activated partial thromboplastin time was elevated in HA group. Urinary output, creatinine and urea levels did not differ between the two groups. Serum calcium, total protein levels were lower in HES group. HA treated infants tended to have shorter ICU and hospital stays. We conclude that none of the investigated colloid solutions were without leverage to infants. Consequently randomized controlled trials about perioperative goal-directed fluid replacement of children undergoing (neuro)-surgery with major blood loss are needed.
1000 Sacherschließung
lokal Hydroxyethyl Starch Derivatives [MeSH]
lokal Plasma Substitutes/therapeutic use [MeSH]
lokal Humans [MeSH]
lokal Retrospective Studies [MeSH]
lokal Hydroxyethylstarch
lokal Crystalloid
lokal Research Note
lokal Fluid Therapy [MeSH]
lokal Infant [MeSH]
lokal Pediatric neurosurgery
lokal HES
lokal Volume substitution
lokal Colloid
lokal Child [MeSH]
lokal Neurosurgery [MeSH]
lokal Human albumin
lokal Serum Albumin, Human [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3457-3002|https://frl.publisso.de/adhoc/uri/UGlwcGlyLCBKb25hcw==|https://frl.publisso.de/adhoc/uri/U3RydWNrLCBNYW51ZWwgRi4=|https://frl.publisso.de/adhoc/uri/QnJ1Z2dlciwgSsO8cmdlbg==|https://frl.publisso.de/adhoc/uri/TmV1aGF1cywgV2luZnJpZWQ=|https://frl.publisso.de/adhoc/uri/V3VuZGVyLCBDaHJpc3RpYW4=
1000 Hinweis
  • DeepGreen-ID: 102701cbd72d4fa4a0cba6b22b0f5c76 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463975.rdf
1000 Erstellt am 2023-11-15T23:14:33.012+0100
1000 Erstellt von 322
1000 beschreibt frl:6463975
1000 Zuletzt bearbeitet Thu Nov 30 22:44:15 CET 2023
1000 Objekt bearb. Thu Nov 30 22:44:15 CET 2023
1000 Vgl. frl:6463975
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463975 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source